Skip to main content
. 2023 Feb 27;10:1016243. doi: 10.3389/fnut.2023.1016243

Table 2.

Two-sample MR estimates of relationship between genetically predicted micronutrients and cancer.

Exposure MR Method Prostate cancer Bladder cancer Renal cell cancer (Female) Renal cell cancer (Male)
No. of SNPs OR (95% CI) P -Value No. of SNPs OR (95% CI) P -Value No. of SNPs OR (95% CI P -Value No. of SNPs OR (95% CI P -Value
Copper IVW 2 1.005 (0.952–1.061) 0.867 2 NA NA 2 2.231 (1.524–3.953) <0.001 2 3.021 (2.204–4.687) <0.001
Iron IVW 3 0.951 (0.896–1.011) 0.106 2 1.000 (0.999–1.001) 0.794 2 1.484 (1.197–2.337) 0.0210 2 1.595 (1.310–1.758) 0.0238
MR-Egger 3 0.917 (0.814–1.034) 0.392 NA NA NA NA NA NA NA NA NA
WM 3 0.954 (0.892–1.020) 0.170 NA NA NA NA NA NA NA NA NA
Zinc IVW 2 1.058 (1.002–1.116) 0.0403 NA NA NA 2 0.124 (0.0434–0.356) <0.001 2 0.131 (0.0159–0.208) <0.001
Wald ratio NA NA NA 1 1.001 (1.000–1.002) 0.0841 NA NA NA NA NA NA
Blood selenium IVW 22 0.996 (0.975–1.017) 0.676 9 0.998 (0.997–0.999) 0.0317 22 0.790 (0.0779–8.030) 0.842 22 0.702 (0.0712–6.919) 0.762
MR-Egger 22 1.023 (0.943–1.110) 0.595 9 0.999 (0.997–1.000) 0.560 22 1.070 (0.0991–1.9652) 0.166 22 3.858 (0.584–8.340) 0.203
WM 22 1.003 (0.976–1.031) 0.835 9 1.000 (0.999–1.000) 0.0612 22 1.851 (0.918–2.977) 0.201 22 2.135 (1.940–2.387) 0.073
Blood and toenail selenium IVW 12 0.985 (0.946–1.025) 0.458 4 0.999 (0.998–1.002) 0.182 12 0.175 (0.004–8.244) 0.375 11 0.0960 (0.00173–5.319) 0.253
MR-Egger 12 1.044 (0.912–1.196) 0.545 4 1.000 (0.997–1.003) 0.213 12 0.08715 (0.0052–0.1597) 0.0257 11 1.7553 (0.4133–2.9804) 0.0570
WM 12 0.985 (0.946–1.025) 0.452 4 0.999 (0.998–1.000) 0.986 12 0.224 (0.085–0.397) <0.001 11 0.283 (0.0173–0.537) 0.0408

OR, odds ratio; CI, confidential interval; IVW, inverse-variance weight; WM, weighted median; SNP, single nucleotide polymorphisms; N.A., not available.